Related Experiment Video
Updated: Sep 20, 2025

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Post Surgical Non-tuberculous Mycobacterium: A Case Series
Ashok N Mhaske1, Shubhangi Mhaske2, Sanjay Harke3
1Department of Surgery, People's College of Medical Sciences and Research Centre, People's University, Bhopal, IND.
Non-tuberculous mycobacteria (NTM) infections are an uncommon but growing concern following surgery. This study found NTM in 6 of 25 post-surgical wound infections, highlighting the need for accurate diagnostics and treatment.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Surgical Infections
Background:
- Reports of human non-tuberculous mycobacteria (NTM) infections are increasing.
- Surgeons are concerned about the potential link between NTM and surgical site infections (SSIs).
- The prevalence of NTM as a cause of SSIs remains challenging to ascertain.
Purpose of the Study:
- To investigate the occurrence of NTM infections following various surgical procedures.
- To determine the incidence of NTM in post-surgical wound infections.
- To identify NTM species and their antibiotic susceptibility patterns.
Main Methods:
- A prospective study was conducted over two years at a tertiary care hospital in central India.
- Six out of 25 post-surgical wound infections were identified as NTM.
- Species identification utilized Ziehl-Neelsen staining, Auramine O-Rhodamine fluorescence staining, Multiplex Real-Time PCR, and Genotyping.
Main Results:
- M. fortuitum, M. chelonae, and M. kansasii were each isolated in two cases.
- All NTM isolates demonstrated 100% sensitivity to Clarithromycin.
- One patient required amikacin in addition to clarithromycin for prolonged healing.
Conclusions:
- Non-tuberculous mycobacteria represent an uncommon but significant cause of post-surgical infections.
- Accurate identification of NTM species using sensitive diagnostic techniques is crucial.
- Developing appropriate therapeutic regimens is essential to manage this increasing healthcare challenge.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

